Core Viewpoint - Lepu Medical's stock price has shown significant growth this year, with a year-to-date increase of 63.83% and a recent trading volume indicating strong investor interest [1][2]. Financial Performance - For the first half of 2025, Lepu Medical reported a revenue of 3.369 billion yuan, a year-on-year decrease of 0.43%, and a net profit attributable to shareholders of 691 million yuan, down 0.91% compared to the previous year [2]. - The company has distributed a total of 4.957 billion yuan in dividends since its A-share listing, with 2.058 billion yuan distributed over the last three years [3]. Shareholder Structure - As of June 30, 2025, Lepu Medical had 100,100 shareholders, an increase of 6.18% from the previous period, with an average of 16,152 circulating shares per shareholder, down 5.82% [2]. - The top ten circulating shareholders include notable ETFs, with Huabao Zhongzheng Medical ETF holding 43.7211 million shares, an increase of 701,700 shares from the previous period [3]. Market Activity - On October 21, Lepu Medical's stock rose by 2.09%, reaching 18.10 yuan per share, with a trading volume of 280 million yuan and a turnover rate of 0.97% [1]. - The stock has seen a net inflow of 19.9078 million yuan from major funds, with significant buying activity noted in large orders [1].
乐普医疗涨2.09%,成交额2.80亿元,主力资金净流入1990.78万元